EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 26-Oct-2026 19:16 ET (26-Oct-2026 23:16 GMT/UTC)

15-Jun-2026

Study of 5.8 billion medicines dispensed in England exposes stark health inequalities

Health Data Research UK
Peer-Reviewed Publication

Scientists have revealed striking inequalities and changing trends in medicines dispensing for more than 52 million people living in England during and after the COVID-19 pandemic.

Journal: Nature Health
Funder: National Institute for Health Research, British Heart Foundation

15-Jun-2026

Report calls for evidence-based strategies to address Alzheimer's-related psychosis

The Gerontological Society of America
Reports and Proceedings

“Alzheimer’s-Related Psychosis: Interdisciplinary Perspectives for Understanding and Responding to Delusions and Hallucinations” — the latest report in The Gerontological Society of America’s Insights & Implications in Gerontology series — underscores the clinical, emotional, and societal impact of psychosis in individuals living with Alzheimer’s disease and stresses the need for comprehensive, person-centered approaches to care.

Funder: Bristol-Myers Squibb

15-Jun-2026

IU collaboration to use AI in identifying possible drug targets for Alzheimer’s patients

Indiana University
Grant and Award Announcement

The IU School of Medicine and the Luddy School of Informatics, Computing and Engineering will attempt to find new treatments for Alzheimer's disease.

15-Jun-2026

HPV therapeutic vaccine shows safety but uncertain benefit in preventing head and neck cancer recurrence

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – June 15, 2026 – A new research paper was published in Volume 17 of Oncotarget on June 5, 2026, titled “A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence.”

Journal: Oncotarget

15-Jun-2026

Study finds students with highest distress use AI for mental health at elevated rates

Brigham and Women's Hospital
Peer-Reviewed Publication

College students have rapidly adopted generative AI, but critical questions remain about its use for mental health support. In a study co-led by investigators at Mass General Brigham, 18% of surveyed college students reported using artificial intelligence (AI) for mental health. Students with more severe mental health symptoms were more likely to do so. The findings are published in the Journal of Affective Disorders.

Journal: Journal of Affective Disorders

15-Jun-2026

New treatment combination delays multiple myeloma progression and may improve survival, study finds

Wake Forest University School of Medicine
Peer-Reviewed Publication

Patients with relapsed multiple myeloma lived significantly longer without disease progression and showed early survival gains in a global phase 3 trial of a talquetamab-based immunotherapy combo, offering new hope for improved treatment outcomes.

Journal: New England Journal of Medicine
Funder: Janssen Biotech

15-Jun-2026

CBT can help after a broken heart

Uppsala University
Peer-Reviewed Publication

Men are over-represented when it comes to heart disease, but there are certain conditions that mainly affect women, such as ‘broken-heart syndrome’. Stress and anxiety are common in this group. A new study led by researchers at Uppsala University and Karolinska Institutet shows that internet-based CBT can reduce symptoms and help patients manage their emotions better.

Journal: Journal of the American Heart Association
Funder: The Swedish Heart and Lung Association, The Swedish Heart Lung Foundation, Vetenskapsrådet, A donation from the Wallenius-Kleberg family

15-Jun-2026

Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity

Weill Cornell Medicine
Peer-Reviewed Publication

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering. The particles, derived from silicon dioxide, a common component of healthy foods or fossilized sedimentary structures from single-celled organisms, induced several complete remissions of aggressive tumors in mouse models, supporting the further investigation of their use in clinical trials.

Journal: Cancer Research

15-Jun-2026

Which GLP-1 medication is most effective for weight loss?

University of Georgia
Peer-Reviewed Publication

GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.

Journal: Obesity